PYXS Pyxis Oncology, Inc.

NEUTRAL Impact: 2/10 DEFA14A
Horizon days Filed Apr 30, 2026 Processed 1mo ago SEC 0001193125-26-194051
Proxy solicitation materials
Latest settled — T+20d
PYXS ▲ +5.88% at T+20d
NEUTRAL call ✓ call won +5.88% · α vs SPY +0.66% · entry $1.70 → $1.80
Next anchor: T+60d in 7w
Currently $1.70 · +0.00% from $1.70 entry
Entry anchored
Apr 30, 2026
via day open
T+1d
+1.18%
call +1.18% · α +0.96%
$1.72
settled 6w ago
T+5d
+32.94%
call +32.94% · α +31.21%
$2.26
settled 5w ago
T+20d
+5.88%
call +5.88% · α +0.66%
$1.80
settled 12d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Pyxis Oncology filed a DEFA14A notice of internet availability of proxy materials for its 2024 Annual Meeting of Stockholders, scheduled for June 11, 2024. The agenda includes the election of one Class I director and three Class III directors, and ratification of Ernst & Young as independent auditor. The board recommends a vote FOR all proposals. This is a routine administrative filing with no material financial impact.

Actionable Insight

Routine proxy notice — no trading signal. Monitor the June 11 meeting for any unexpected voting outcomes or dissident activity, though none is indicated in this filing.

Key Facts

  • Annual Meeting of Stockholders scheduled for June 11, 2024
  • Record date: April 18, 2024
  • Proposal 1: Election of one Class I director (Santhosh Palani) and three Class III directors (John Flavin, Lara Sullivan, Jakob Dupont)
  • Proposal 2: Ratification of Ernst & Young LLP as independent auditor for FY 2024
  • Board recommends a vote FOR both proposals
  • Filing is a notice of internet availability of proxy materials (DEFA14A)

Financial Impact

No financial figures disclosed in this filing

Risk Factors

  • No material risks identified from this routine filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (15 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-194051
Document: 0001193125-26-194051-index-headers.html0001193125-26-194051
Document: 0001193125-26-194051-index.html0001193125-26-194051
Document: 0001193125-26-194051.txt0001193125-26-194051
5 reports for PYXS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PYXS — sortable, filterable
Type Now
May 14, 2026
26d ago
8-K
NEUTRAL ★ 5/10
$2.21 $1.94▼ −12.22%▼ −11.50%$1.70 (−23.08%)
May 14, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$2.21 $1.94▼ −12.22%▼ −11.50%$1.70 (−23.08%)
Apr 30, 2026
5w ago
DEFA14A
NEUTRAL ★ 2/10
$1.70 $2.26▲ +32.94%▲ +31.21%$1.70 (+0.00%)
Apr 17, 2026
7w ago
Press Release
BULLISH ★ 7/10
$1.70 $1.76▲ +3.53%▲ +2.62%$1.70 (+0.00%)
Mar 23, 2026
11w ago
Press Release
MIXED ★ 6/10
$1.42 $1.27▼ −10.56%▼ −7.00%$1.70 (+19.72%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (9h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access